{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:16:23Z","timestamp":1788423383846,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking Union Medical College Hospital Talent Cultivation Program","award":["UHB12044"],"award-info":[{"award-number":["UHB12044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05445-2","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:54:48Z","timestamp":1784721288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term epidemiology of bacterial pathogens and antimicrobial resistance in a secondary hospital in China: a 12-year retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Li","family":"Yingxing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fangyuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wenting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Hongmei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"5445_CR1","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. J Med Surg Public Health. 2024;2:100081. https:\/\/doi.org\/10.1016\/j.glmedi.2024.100081.","journal-title":"J Med Surg Public Health"},{"key":"5445_CR2","doi-asserted-by":"publisher","unstructured":"Oliveira M, Antunes W, Mota S, Madureira-Carvalho A, Dinis-Oliveira RJ. Dias da Silva D. An Overview of the Recent Advances in Antimicrobial Resistance. Microorganisms. 2024;12(9). https:\/\/doi.org\/10.3390\/microorganisms12091920.","DOI":"10.3390\/microorganisms12091920"},{"issue":"10325","key":"5445_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"issue":"10459","key":"5445_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1.","journal-title":"Lancet"},{"key":"5445_CR5","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.3389\/bjbs.2023.11387","volume":"80","author":"KWK Tang","year":"2023","unstructured":"Tang KWK, Millar BC, Moore JE. Antimicrobial Resistance (AMR). Br J Biomed Sci. 2023;80:11387. https:\/\/doi.org\/10.3389\/bjbs.2023.11387.","journal-title":"Br J Biomed Sci"},{"key":"5445_CR6","doi-asserted-by":"publisher","unstructured":"George NA, Pan D, Silva L, Baggaley RF, Irizar P, Divall P, et al. The prevalence and risk of mortality associated with antimicrobial resistance within nosocomial settings-a global systematic review and meta-analysis of over 20,000 patients. eClinicalMedicine. 2025;87. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103384.","DOI":"10.1016\/j.eclinm.2025.103384"},{"issue":"3","key":"5445_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5445_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.18502\/ijm.v15i3.12896","volume":"15","author":"S Kadivarian","year":"2023","unstructured":"Kadivarian S, Rostamian M, Dashtbin S, Kooti S, Zangeneh Z, Abiri R, et al. High burden of MDR, XDR, PDR, and MBL producing Gram negative bacteria causing infections in Kermanshah health centers during 2019\u20132020. Iran J Microbiol. 2023;15(3):359\u201372. https:\/\/doi.org\/10.18502\/ijm.v15i3.12896.","journal-title":"Iran J Microbiol"},{"key":"5445_CR9","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/idr.S480829","volume":"17","author":"K Ulu\u00e7","year":"2024","unstructured":"Ulu\u00e7 K, Kutbay \u00d6z\u00e7elik H, Akk\u00fct\u00fck \u00d6ngel E, H\u0131r\u00e7\u0131n Cenger D, \u00c7olako\u011flu \u015eM, K\u00f6yl\u00fc Ilkaya N, et al. The Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Infections in Respiratory Intensive Care Unit, Causative Microorganisms and Mortality. Infect Drug Resist. 2024;17:4913\u20139. https:\/\/doi.org\/10.2147\/idr.S480829.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"5445_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller WR, Arias CA. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat Rev Microbiol. 2024;22(10):598\u2013616. https:\/\/doi.org\/10.1038\/s41579-024-01054-w.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"5445_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025;25(9):1033\u201343. https:\/\/doi.org\/10.1016\/S1473-3099(25)00118-5.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5445_CR12","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2214-109X(23)00539-9","volume":"12","author":"B Sartorius","year":"2024","unstructured":"Sartorius B, Gray AP, Davis Weaver N, Robles Aguilar G, Swetschinski LR, Ikuta KS, et al. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Global Health. 2024;12(2):e201\u201316. https:\/\/doi.org\/10.1016\/S2214-109X(23)00539-9.","journal-title":"Lancet Global Health"},{"issue":"Suppl 7","key":"5445_CR13","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis. 2019;69(Suppl 7):S521\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz824.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5445_CR14","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/s2468-2667(22)00225-0","volume":"7","author":"European Antimicrobial Resistance Collaborators","year":"2022","unstructured":"European Antimicrobial Resistance Collaborators. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health. 2022;7(11):e897\u2013913. https:\/\/doi.org\/10.1016\/s2468-2667(22)00225-0.","journal-title":"Lancet Public Health"},{"key":"5445_CR15","doi-asserted-by":"publisher","first-page":"100561","DOI":"10.1016\/j.lana.2023.100561","volume":"25","author":"Antimicrobial Resistance Collaborators","year":"2023","unstructured":"Antimicrobial Resistance Collaborators. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. Lancet Reg Health Am. 2023;25:100561. https:\/\/doi.org\/10.1016\/j.lana.2023.100561.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"5445_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2049936115621709","volume":"3","author":"G Meletis","year":"2016","unstructured":"Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):15\u201321. https:\/\/doi.org\/10.1177\/2049936115621709.","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"5445_CR17","doi-asserted-by":"publisher","first-page":"ofx176","DOI":"10.1093\/ofid\/ofx176","volume":"4","author":"B Cai","year":"2017","unstructured":"Cai B, Echols R, Magee G, Arjona Ferreira JC, Morgan G, Ariyasu M, et al. Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4(3):ofx176. https:\/\/doi.org\/10.1093\/ofid\/ofx176.","journal-title":"Open Forum Infect Dis"},{"key":"5445_CR18","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.2147\/IDR.S573970","volume":"18","author":"L Liu","year":"2025","unstructured":"Liu L, Huang Y, Jiang Y, Wang Y, Liu K, Pei Z, et al. Distribution Features and Antimicrobial Resistance Trends of Clinical Pathogens: A Retrospective Study in a Tertiary Teaching Hospital in East China (2020\u20132024). Infect Drug Resist. 2025;18:6889\u2013903. https:\/\/doi.org\/10.2147\/IDR.S573970.","journal-title":"Infect Drug Resist"},{"key":"5445_CR19","unstructured":"National Health Commission of the People\u2019s Republic of China. 2024 Statistical Bulletin on the Development of China\u2019s Health Care Undertakings. National Health Commission official website. 2025. Available from: https:\/\/www.nhc.gov.cn\/guihuaxxs\/c100133\/202512\/f1c3a3c617484a27a1a26a468afbaeee.shtml."},{"issue":"1","key":"5445_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s44280-025-00092-0","volume":"3","author":"Y Guo","year":"2025","unstructured":"Guo Y, Ding L, Han R, Yin D, Wu S, Yang Y, et al. Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report. One Health Adv. 2025;3(1):23. https:\/\/doi.org\/10.1186\/s44280-025-00092-0.","journal-title":"One Health Adv"},{"key":"5445_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3969\/j.issn.1674-3296.2010.14.099","volume":"14","author":"P Chao","year":"2010","unstructured":"Chao P. Evaluation of XK automatic microbial identification and antimicrobial susceptibility analysis system. Chin J Clin Ration Drug Use. 2010;14:123\u20134. https:\/\/doi.org\/10.3969\/j.issn.1674-3296.2010.14.099.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"1","key":"5445_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s44280-023-00009-9","volume":"1","author":"W Yang","year":"2023","unstructured":"Yang W, Ding L, Han R, Yin D, Wu S, Yang Y, et al. Current status and trends of antimicrobial resistance among clinical isolates in China: a retrospective study of CHINET from 2018 to 2022. One Health Adv. 2023;1(1):8. https:\/\/doi.org\/10.1186\/s44280-023-00009-9.","journal-title":"One Health Adv"},{"issue":"Supplement1","key":"5445_CR23","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","volume":"6","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN. Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program. Open Forum Infect Dis. 2019;6(Supplement1):S47\u201353. https:\/\/doi.org\/10.1093\/ofid\/ofy270.","journal-title":"Open Forum Infect Dis"},{"key":"5445_CR24","doi-asserted-by":"publisher","first-page":"1045206","DOI":"10.3389\/fmicb.2022.1045206","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Ding Y, Wei Y, Jian C, Liu J, Zeng Z. Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit. Front Microbiol. 2022;13:1045206. https:\/\/doi.org\/10.3389\/fmicb.2022.1045206.","journal-title":"Front Microbiol"},{"key":"5445_CR25","doi-asserted-by":"publisher","first-page":"8042540","DOI":"10.1155\/2020\/8042540","volume":"2020","author":"I Odongo","year":"2020","unstructured":"Odongo I, Ssemambo R, Kungu JM. Prevalence of Escherichia Coli and Its Antimicrobial Susceptibility Profiles among Patients with UTI at Mulago Hospital, Kampala, Uganda. Interdiscip Perspect Infect Dis. 2020;2020:8042540. https:\/\/doi.org\/10.1155\/2020\/8042540.","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"2","key":"5445_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/antibiotics15020232","volume":"15","author":"M Miron","year":"2026","unstructured":"Miron M, Ristescu AI, Blaj M, Iosep DG, Oancea A-F, Iosep G, et al. Clinical and Microbiological Profile of Hospital-Acquired and Ventilator-Associated Pneumonia in Critically Ill Patients: A Retrospective Observational Study. Antibiotics. 2026;15(2):232.","journal-title":"Antibiotics"},{"key":"5445_CR27","doi-asserted-by":"publisher","unstructured":"Linz MS, Mattappallil A, Finkel D, Parker D. Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections. Antibiot (Basel). 2023;12(3). https:\/\/doi.org\/10.3390\/antibiotics12030557.","DOI":"10.3390\/antibiotics12030557"},{"issue":"1","key":"5445_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-014-0039-y","volume":"3","author":"JT Spadafino","year":"2014","unstructured":"Spadafino JT, Cohen B, Liu J, Larson E. Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3(1):39. https:\/\/doi.org\/10.1186\/s13756-014-0039-y.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"5445_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmi.2020.10.016","volume":"27","author":"ZR Palacios-Baena","year":"2021","unstructured":"Palacios-Baena ZR, Giannella M, Manissero D, Rodr\u00edguez-Ba\u00f1o J, Viale P, Lopes S, et al. Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clin Microbiol Infect. 2021;27(2):228\u201335. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.016.","journal-title":"Clin Microbiol Infect"},{"key":"5445_CR30","doi-asserted-by":"publisher","first-page":"3168325","DOI":"10.1155\/2020\/3168325","volume":"2020","author":"Y Tsige","year":"2020","unstructured":"Tsige Y, Tadesse S, Tefera TGE, Amsalu MM, Menberu A. Prevalence of Methicillin-Resistant Staphylococcus aureus and Associated Risk Factors among Patients with Wound Infection at Referral Hospital, Northeast Ethiopia. J Pathog. 2020;2020:3168325. https:\/\/doi.org\/10.1155\/2020\/3168325.","journal-title":"J Pathog"},{"issue":"1","key":"5445_CR31","doi-asserted-by":"publisher","first-page":"e0226624","DOI":"10.1128\/spectrum.02266-24","volume":"13","author":"Y Li","year":"2025","unstructured":"Li Y, Yang W, Li Y, Hua K, Zhao Y, Wang T, et al. The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China. Microbiol Spectr. 2025;13(1):e0226624. https:\/\/doi.org\/10.1128\/spectrum.02266-24.","journal-title":"Microbiol Spectr"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05445-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:02:20Z","timestamp":1788422540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5445"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05445-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Institutional Review Board of Xintai Second People\u2019s Hospital, Tai\u2019an, China (reference number 2026-LLYJ-01-01). Patient data were fully de-identified before analysis, and the requirement for informed consent was waived by the Institutional Review Board because of the retrospective nature of the study. All procedures involving human data were performed in accordance with the Declaration of Helsinki and relevant institutional guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"775"}}